Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Фармацевтический УниверситетfiledCriticalНациональный Фармацевтический Университет
Priority to UAA200815305ApriorityCriticalpatent/UA92646C2/ru
Publication of UA92646C2publicationCriticalpatent/UA92646C2/ru
UAA200815305A2008-12-302008-12-30применение производных 2-оксоиндолин-3-глиоксиловой кислоты в качестве средств с актопротекторным действием
UA92646C2
(ru)
miRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway